Northrop Grumman Corporation is a U.S. aerospace and defense prime contractor, not an exchange-traded fund, so the target in this analysis is derived from sell-side analyst price targets rather than fund flows or index methodology. The central target of $620 represents the arithmetic mean of more than a dozen current, individually attributable price targets reviewed, rounded to a reader-friendly level. It should not be read as an official published consensus.
The current target range is unusually wide. On the cautious end, Barclays initiated coverage with an Underweight rating and a $419 target in early October 2026. On the bullish end, BTIG maintained a Buy with an $815 target in August 2026. Between these extremes sit names such as Citi ($667), Susquehanna ($655), Rothschild & Co Redburn ($680), Argus Research ($700), Morgan Stanley ($745), Wells Fargo ($620), Bernstein ($660), J.P. Morgan ($600), Jefferies ($580), and Goldman Sachs ($538). Major data providers tracking roughly 25 analysts report an average in the $620 to $640 range, consistent with the calculated mean.
The dispersion reflects genuine disagreement about the balance between Northrop's durable franchise and mounting policy risk. Several firms lowered targets during mid-2026, including Goldman Sachs, TD Cowen, Citi, and Wells Fargo, while Morgan Stanley named the stock a "Top Pick" in defense in July 2026 and Barclays broke from the pack with a bearish initiation. The result is a Moderate Buy consensus with no clean agreement on valuation.
Northrop Grumman shares closed at $519.86 on October 16, 2026. To reach the $620 central target, the stock would need to advance roughly 19%, a substantial but not extraordinary move for a large-cap name over a typical research horizon. The stock's 52-week range of $470.06 to $774.00 underscores how volatile the shares have been: the company traded near $774 as recently as March 2026 before a sharp pullback driven by defense budget and policy uncertainty.
The stock has spent recent weeks rebuilding from its early-October low near $470, recovering toward the $520 level. A sustained move toward $620 would likely require renewed confidence in future defense appropriations, continued program execution, and a stabilization or re-rating of the stock's valuation multiple, which currently reflects elevated skepticism about capital-return policy and budget visibility.
The stock's technical structure has deteriorated from its early-2026 peak but is attempting to stabilize. The $470 area, marked by the early-October low, is a key support level that has held so far. Below that, there is little established support until lower levels. On the upside, the $540 to $550 zone acted as resistance during the recent recovery and would need to be cleared before a move toward $600 to $620 becomes credible. The prior 52-week high near $774 represents the upper boundary of the recent trading range and a reminder of how far the shares fell.
Analyst price targets generally reflect a roughly 12-month research horizon, though individual firms apply different assumptions about budgets, program execution, and valuation, which explains the wide range. Investors should watch the company's quarterly earnings report, scheduled for late October 2026, along with any updates to guidance and the backlog. Defense budget negotiations in Washington, capital-allocation and buyback policy signals, analyst target revisions, and broader interest-rate expectations are all likely to influence the path toward the target. No timing estimate is implied by the $620 figure.
For traders monitoring Northrop Grumman and the broader market, Tickeron's AI Daily Buy/Sell Signals offer a data-driven complement to traditional research. The platform uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Traders can use these signals to discover new opportunities, track open positions, and identify shifting trends more efficiently than manual screening alone. As defense-policy headlines continue to move NOC, real-time signal tools can help investors stay ahead of momentum shifts.
The question of whether Northrop Grumman can reach $620 hinges on whether investors regain confidence in defense budget visibility and the company's capital-return trajectory. The central target, derived from the mean of current analyst targets, sits about 19% above the latest price, a substantial move that is achievable only if the bearish case articulated by firms such as Barclays proves too conservative. Support comes from a strong backlog, execution, and a Moderate Buy consensus, while the principal obstacles are policy uncertainty, possible buyback constraints, and a wide, still-falling range of analyst estimates. With the shares recovering off support but facing resistance near $540 to $550, upcoming earnings and budget developments will be decisive. No outcome is guaranteed, and the target is an analytical reference point rather than a forecast.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, NOC has been closely correlated with LMT. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if NOC jumps, then LMT could also see price increases.